Subcutaneous implantable cardioverter defibrillators (S‐ICDs) avoid complications secondary to transvenous leads, but inappropriate shocks (ISs) are frequent. Furthermore, IS data from patients with Brugada syndrome (BrS) with an S‐ICD are… Click to show full abstract
Subcutaneous implantable cardioverter defibrillators (S‐ICDs) avoid complications secondary to transvenous leads, but inappropriate shocks (ISs) are frequent. Furthermore, IS data from patients with Brugada syndrome (BrS) with an S‐ICD are scarce.
               
Click one of the above tabs to view related content.